The Efficacy and Mechanism of SMA+M1 Repetitive Transcranial Magnetic Stimulation on Freezing of Gait in PD - Trial NCT06415682
Access comprehensive clinical trial information for NCT06415682 through Pure Global AI's free database. This phase not specified trial is sponsored by The First Affiliated Hospital with Nanjing Medical University and is currently Not yet recruiting. The study focuses on Parkinson Disease. Target enrollment is 53 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
The First Affiliated Hospital with Nanjing Medical University
Timeline & Enrollment
N/A
May 06, 2024
Dec 06, 2024
Primary Outcome
Changes of Freezing of Gait severity
Summary
This study is a double-blinded randomized study examining the efficacy of the double-site
 (M1+SMA) repetitive transcranial magnetic stimulation on Freezing of Gait (FOG) in patients
 with Parkinson's disease. The investigators hypothesize that treatment using magnetic
 stimulation on double site (including M1-LL and SMA) will improve FOG and gait symptoms in
 patients with Parkinson's disease.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06415682
Device Trial